In addition, the proportion of nalidixic-acid-resistant isolates increased markedly from 17% (between 2007 and 2010) to 52% (since 2011). In April 2014, an S. Stanley outbreak with a PFGE pattern indistinguishable from the 2011–2012 outbreak strain was identified in Austria.